Analysed TEMPUS AI INC-CL A (TEM:NASDAQ) News Sources
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
21-05-2026
yahoo.com
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology Algorithm
24-05-2026
yahoo.com
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
26-05-2026
yahoo.com
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
27-05-2026
yahoo.com
What is the current price of TEMPUS AI INC-CL A (TEM:NASDAQ)?
The current price of TEMPUS AI INC-CL A (TEM:NASDAQ) is $51.29.
TEMPUS AI INC-CL A (TEM:NASDAQ) absolute price change since previous trading day?
The absolute price change of TEMPUS AI INC-CL A (TEM:NASDAQ) since the previous trading day is $4.12.
TEMPUS AI INC-CL A (TEM:NASDAQ) percentage price change since previous trading day?
The percentage price change of TEMPUS AI INC-CL A (TEM:NASDAQ) since the previous trading day is 8.7344%.
What is the most recent average sentiment score for TEMPUS AI INC-CL A (TEM:NASDAQ)?
The most recent average sentiment score for TEMPUS AI INC-CL A (TEM:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for TEMPUS AI INC-CL A (TEM:NASDAQ)?
The most recent sentiment for TEMPUS AI INC-CL A (TEM:NASDAQ) is .
SEC-8K** Filing Available For TEMPUS AI INC-CL A (TEM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.